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Enhancement of Varicella-Zoster-Specific Immune Responses in the Elderly by
Boosting with Varicella Vaccine
Legend. Varicella-zoster virus (VZV)-specific cell-me-
diated immunity in 33 adult volunteers (age range, 55-65
years) before and two months after inoculation with live
VZV vaccine. The subjects, who had previously been
screened for a negative proliferative immune response to
VZV antigen in an in vitro serum assay, were vaccinated
with aKA-strain VZV vaccine (2,700 pfu; SmithKline-
RIT, Rixensart, Belgium). Blood sampling was done on
the day of vaccination and two months later. Lympho-
cytes were isolated by Ficoll-Hypaque separation. Cells
(5 x 105)were cultivated in the presence of VZV antigen
(sonicated VZV-infected MA 184 human foreskin fibro-
blasts) or control antigen (sonicated uninfected fibro-
blasts) after five and six days. 125I-iododeoxiuridine
(1.25 J.lCi) and fluorodeoxiuridine (l0-6M) were added.
After 18 hr the cells were harvested on paper disks,
and the tracer incorporation was counted in a gamma
counter. The geometric mean of three determinations
was used for the calculation of the specific increase (cpm
of VZV - cpm of control) and the stimulation index
(SI; cpm of VZV/cmp of control). Cell-mediated im-
mune responses with a specific increase of 2,500 cpm and
an SI of <3 were considered negative (.), those with a
specific increase of 2,500-6,000 and an SI of 3-5 were
considered weakly positive (0), and those with a specific
increase >6,000 and an SI of >5 were considered positive
(0). Humoral antibodies to VZV were determined by
ELISA (Varicella Enzygnost'", Behring, Marburg, West
Germany).
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Summary
During the evaluation of specific immune responses to
VZV in healthy elderly people, we observed an impair-
ment of the lymphocyte transformation by VZV antigen
in vitro despite normal values for the cell-mediated
immune response to mitogens [1]. Our results were con-
firmed by Burke et al [2], who also reported reduced
skin-test reactivity to VZV antigen in older age groups.
Approximately 20010 of 55- to 65-year-old healthy people
with a confirmed history of chickenpox and humoral
antibodies to VZV show a negative lymphoproliferative
immune response to VZV antigen. The possibility of a
correlation between this observation and the fact that
shortly after the appearance of clinical symptoms in
herpes-zoster infections the cell-mediated immune re-
sponse to VZV virus is also negative [3] remains to be
established; nevertheless, with a view to the possible
prevention of herpes-zoster, we vaccinated 33 volunteers
having a reduced lymphoproliferative immune response
to VZV with live aKA-strain VZV vaccine. In 28 (85%)
of the volunteers the vaccination induced a change from
a negative to a positive cell-mediated immune response
to VZV antigen in vitro; we do not yet know why no
stimulation was observed in the other five (15%), but we
hope to be able to present some explanations by testing
the function of the suppressor/helper cells and the
plasma factors. In all subjects humoral antibodies to
VZV were present prior to administration of the booster
vaccination. An increase in antibody titer was observed
in >50070 of our vaccinees, suggesting at least some VZV
replication, despite preexisting humoral antibodies. Re-
testing of a few of our volunteers one year after vaccina-
tion showed that the boosting effect remained. The most
important question remaining to be answered - whether
such an improvement in the lymphoproliferative im-
mune response to VZV does in fact give protection
against herpes-zoster infection - can only be answered
by the clinical evaluation of a large number of vaccinees
over a period of several years.
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